Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
TETeva Pharmaceutical Industries Limited logo

Teva Pharmaceutical Industries Limited (TEVA)

New York Stock Exchange · Currency in USD
$39.41 ▼ -0.80 (-1.99%)
At close: Oct 23, 4:00 PM ET. Market closed.
$39.40 ▼ -0.01 (-0.03%)
After hours: Oct 23, 5:29 PM ET

Summary

Previous Close
$40.21
Open
$39.75
Day's Range
$39.11 – $39.84
52 Week Range
$19.00 – $42.02
Volume
5,596,486
Avg. Volume
5,604,936
Market Cap
$45.92B
Beta (5Y Monthly)
0.82
PE Ratio (TTM)
62.56
EPS (TTM)
$0.61
Earnings Date
Nov 3, 2026
Forward Dividend & Yield
$0.34 (0.86%)
Ex-Dividend Date
Nov 27, 2017
1y Target Est
$47.33

Profile: Teva Pharmaceutical Industries Limited

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
32,008
CEO
Richard D. Francis

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs).

Earnings

Next report: Tue, Nov 3, 2026
EPS estimate $0.72 · Revenue est. $4.24B
DateEst.Actual
Jul 29, 2026$0.08$0.02Miss
Apr 29, 2026$0.50$0.53Beat
Jan 28, 2026$0.65$0.96Beat
Nov 5, 2025$0.68$0.78Beat
Jul 30, 2025$0.63$0.66Beat
May 7, 2025$0.47$0.52Beat

Analyst view

Consensus price target
$47.33 ▲ +20.1%
Range $44.00 – $50.00
Rating: Buy
Buy 48% · Hold 43% · Sell 9%

Get free alerts on TEVA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.